Synthesis of 6-aziridinylbenzimidazole derivatives and their in vitro antitumor activities

Archives of Pharmacal Research

Volumn 21, Issue 5, 1998, Pages 599-609

  Ahn, Chan Mug ^a   Kim, Soo Kie ^a   Han, Jeong Lim ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Azamitosene; Benzimidazole; Cytotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; AZIRIDINE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; NITROBLUE TETRAZOLIUM; QUINONE DERIVATIVE;

ANIMAL; ARTICLE; CELL CULTURE; DRUG SCREENING; HUMAN; MOUSE; OXIDATION REDUCTION REACTION; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; AZIRIDINES; BENZIMIDAZOLES; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INDICATORS AND REAGENTS; MICE; NITROBLUE TETRAZOLIUM; OXIDATION-REDUCTION; QUINONES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032177316     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02975382     Document Type: Article

References (19)

1. Ahn, C. M. and Baek, H. J., Synthesis of pyrrolo[1,2-a] benzimidazole 3-acetate derivatives. The Journal of Wonju College of Medicine, 6, 231-238 (1993).
2. Ahn, C. M. and Kim, S. K., Synthesis and in vitro antitumor activity of isoazamitosene and isoiminoazamitosene derivatives. Arch. Pharm. Res., 19, 535-542 (1996).
3. Boruah, R. C. and Skibo, E. B., A comparison of the cytotoxic and physical properties of aziridinyl quinone derivatives based on the pyrrolo[1,2-a]benzimidazole and pyrrolo[1,2-a]indole ring systems. J. Med. Chem., 37, 1625-1631 (1995).
4. Carmichel, J., DeGraff, W. G. and Gazdar, A. F., Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assesment of chemosensitivity testing. Cancer. Res. 47, 936-942 (1987).
5. Islam, I. and Skibo, E. B., Synthesis and physical studies of azamitosene and iminoazamitosene reductive alkylating agents. Iminoquinone hydrolytic stability, syn/anti isomerization, and electrochemistry. J. Org. Chem., 55, 3195-3205 (1990).
6. Islam, I. and Skibo, E. B., Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: new reductive alkylating DNA cleaving agents. J. Med. Chem. 34, 2954-2961 (1991).
7. Keyes, S. R., Heimbrook, D. C., Fracasso, P. M., Rockwell, S., Sligar, S. G. and Sartorelli, A. C., Chemotherapeutic attack of hypoxic tumor cells by the bioreductive alkylating agent mitomycin C. Adv. Enz. Reg., 23, 291-307 (1985).
8. Kim, S. K., Ahn, C. M., Choi, S. J., Park, Y. S., Cho, H. C. and Koh, C. M., The growth inhibitory effect of new pyrrolo[1,2-a]benzimidazole derivatives on human gastric cancer cells. Arch. Pharm. Res., 20, 410-413 (1997).
9. March, L. C. and Joullie, M. M., Benzimidazolediones. 1,4-Addition reactions of 4,7-benzimidazoledione (1). J. Het. Chem., 7, 249-256 (1970).
10. Moore, H. W., Bioactivation as a model for drug design bioreductive alkylation. Science, 197, 527-532 (1977).
11. Moore, H. W. and Czerniak, P., Naturally occurring quinones as potential bioreductive alkylating agents. Med. Res. Rev., 1, 249-280 (1981).
12. Perrin, D. D., Armarego, L. F. and Perrin, O. R., Purification of Laboratory Chemicals. 2nd ed., Pergamon Press, New York, 1980.
13. Phillips, M. A., The formation of 2-substituted benzimidazoles. J. Chem. Soc., 2393-2399 (1928).
14. Schulz, W. G., Islam, I. and Skibo, E. B., Pyrrolo[1,2-a] benzimidazole-based quinones and iminoquinones. The role of the 3-substituent on cytotoxicity. J. Med. Chem., 38, 109-118 (1993).
15. Skibo, E. B., Gordon, S., Bess, L., Boruah, R. and Heileman, M. J., Studies of pyrrolo[1,2-α]benzi-midazole quinone DT-diaphorase substrate activity, topoisomerase II inhibition activity, and DNA reductive alkylation. J. Med. Chem., 40, 1327-1339 (1997).
16. Skibo, E. B. and Schulz, W. G., Pyrrolo[1,2-a]benzimidazole-based aziridinyl quinones. A new class of DNA cleaving agent exhibiting G and A Base specificity. J. Med. Chem., 36, 3050-3055 (1993).
17. Tomasz, E. B., Lipman, R., Verdine, G. L. and Nakanish, K., Reassignment of the guanine-binding mode of reduced mitomycin C. Biochemistry, 25, 4337-4344 (1986).
18. Zhou, R. and Skibo, E. B., Chemistry of the pyrrolo[1, 2-a]benzimidazole antitumor agents: Influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II. J. Med. Chem., 39, 4321-4331 (1996).
19. Zimmer, H., Lankin, D. C. and Morgan, S. W., Oxidations with potassium nitrodisulfonate (Fremy's radical). The Teaber reaction. Chemical Reviews, 71, 229-246 (1971).